Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01416
|
|||||
Drug Name |
Enalaprilat
|
|||||
Synonyms |
EAL; Enalaprilate; Enalaprilatum; ENALAPRILAT INHIBITOR; Enalapril acid; Enalapril diacid; Enalaprilat anhydrous; Enalaprilic acid; Enalprilat hydrate; Enalprilate hydrate; Enalaprilat (USP); MK-422; Vasotec I.V.; N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline; N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline-water (1/2); (2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid; (2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid dihydrate; 1-((2S)-2-{[(1S)-1-CARBOXY-3-PHENYLPROPYL]AMINO}PROPANOYL)-L-PROLINE; 1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | High blood pressure [ICD11: BA00] | Approved | [1] | |||
Therapeutic Class |
Antihypertensive Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C18H24N2O5
|
|||||
Canonical SMILES |
CC(C(=O)N1CCCC1C(=O)O)NC(CCC2=CC=CC=C2)C(=O)O
|
|||||
InChI |
InChI=1S/C18H24N2O5/c1-12(16(21)20-11-5-8-15(20)18(24)25)19-14(17(22)23)10-9-13-6-3-2-4-7-13/h2-4,6-7,12,14-15,19H,5,8-11H2,1H3,(H,22,23)(H,24,25)/t12-,14-,15-/m0/s1
|
|||||
InChIKey |
LZFZMUMEGBBDTC-QEJZJMRPSA-N
|
|||||
CAS Number |
CAS 76420-72-9
|
|||||
Pharmaceutical Properties | Molecular Weight | 348.4 | Topological Polar Surface Area | 107 | ||
Heavy Atom Count | 25 | Rotatable Bond Count | 8 | |||
Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 6 | |||
XLogP |
-0.7
|
|||||
PubChem CID | ||||||
PubChem SID |
13885
, 7887268
, 11688562
, 14876097
, 14900718
, 26719866
, 26758015
, 39459536
, 46386741
, 49681611
, 50070755
, 50466382
, 92308386
, 92308980
, 93166910
, 93311012
, 93577953
, 99313641
, 103179234
, 104253291
, 114004069
, 118313442
, 121362057
, 124659029
, 124757412
, 124800027
, 125164216
, 126650398
, 128562671
, 131325846
, 134221872
, 135012534
, 137024395
, 143297080
, 144076246
, 151979549
, 152031989
, 160661062
, 160846356
, 162176890
, 162262134
, 163564990
, 164786777
, 165698333
, 172080415
, 172913628
, 175266379
, 176484234
, 176484707
, 178102950
|
|||||
ChEBI ID |
CHEBI:4786
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | PEPT1 | Transporter Info | Peptide transporter 1 | Substrate | [2] | |
References | ||||||
1 | Enalaprilat was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Transporter-mediated Drug Interactions. Drug Metab Pharmacokinet. 2002;17(4):253-74. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.